B cells under influence: transformation of B cells by Epstein–Barr virus (Q35549146)

8 August 2017

1 reference

title

B cells under influence: transformation of B cells by Epstein-Barr virus (English)

1 reference

8 August 2017

B cells under influence: transformation of B cells by Epstein–Barr virus (English)

1 reference

17 March 2024

0 references

0 references

1 reference

17 March 2024

1

Ralf Küppers

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14523386

17 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://www.nature.com/articles/nri1201.pdf

1 reference

https://www.nature.com/articles/nri1201

17 March 2024

1 reference

Nature Reviews Immunology

17 March 2024

published in

1 reference

8 August 2017

volume

3

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

801-812

1 reference

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

8 August 2017

cites work

1 reference

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

31 March 2020

1 reference

Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer

31 March 2020

1 reference

Is EBV persistence in vivo a model for B cell homeostasis?

31 March 2020

1 reference

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

31 March 2020

1 reference

A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells

31 March 2020

1 reference

Epstein-Barr virus: exploiting the immune system

31 March 2020

1 reference

Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

31 March 2020

1 reference

EBV persistence in memory B cells in vivo.

31 March 2020

1 reference

Unexpected patterns of Epstein-Barr virus gene expression during early stages of B cell transformation

31 March 2020

1 reference

B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression

31 March 2020

1 reference

The dispersal of mucosal memory B cells: evidence from persistent EBV infection

31 March 2020

1 reference

Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma

31 March 2020

1 reference

Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.

31 March 2020

1 reference

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

31 March 2020

1 reference

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

31 March 2020

1 reference

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

31 March 2020

1 reference

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

31 March 2020

1 reference

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

31 March 2020

1 reference

Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

31 March 2020

1 reference

Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells

31 March 2020

1 reference

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

31 March 2020

1 reference

Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

31 March 2020

1 reference

A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues

31 March 2020

1 reference

Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells

31 March 2020

1 reference

TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line

31 March 2020

1 reference

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

31 March 2020

1 reference

Mechanisms of chromosomal translocations in B cell lymphomas

31 March 2020

1 reference

Molecular virology of Epstein-Barr virus

31 March 2020

1 reference

Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction

31 March 2020

1 reference

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

31 March 2020

1 reference

T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines

31 March 2020

1 reference

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

31 March 2020

1 reference

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

31 March 2020

1 reference

Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.

31 March 2020

1 reference

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

31 March 2020

1 reference

Molecular biology of Hodgkin's lymphoma

31 March 2020

1 reference

Mechanism of antigen-driven selection in germinal centres

31 March 2020

1 reference

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

31 March 2020

1 reference

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

31 March 2020

1 reference

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module

31 March 2020

1 reference

Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes

31 March 2020

1 reference

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

31 March 2020

1 reference

Cellular origin of human B-cell lymphomas.

31 March 2020

1 reference

Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease

31 March 2020

1 reference

Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease

31 March 2020

1 reference

In vitro culture of B-lymphocytes derived from epstein-barr-virus-associated posttransplant lymphoproliferative disease: Cytokine production and effect of interferon-alpha

31 March 2020

1 reference

The role of EBV in post-transplant malignancies: a review

31 March 2020

1 reference

Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

31 March 2020

1 reference

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

31 March 2020

1 reference

Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma

31 March 2020

1 reference

A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease

31 March 2020

1 reference

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

31 March 2020

1 reference

Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

31 March 2020

1 reference

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

31 March 2020

1 reference

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

31 March 2020

1 reference

Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma

31 March 2020

1 reference

Lymphoid malignancies: the dark side of B-cell differentiation

31 March 2020

1 reference

The occurrence and significance of V gene mutations in B cell-derived human malignancy

31 March 2020

1 reference

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

31 March 2020

1 reference

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

31 March 2020

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

31 March 2020

1 reference

EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

31 March 2020

1 reference

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

31 March 2020

1 reference

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

31 March 2020

1 reference

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

31 March 2020

1 reference

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

31 March 2020

1 reference

Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus.

31 March 2020

1 reference

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

31 March 2020

1 reference

The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function

31 March 2020

1 reference

Clonal selection and learning in the antibody system

31 March 2020

1 reference

31 March 2020

1 reference

Epstein-Barr virus immortalization and latency

31 March 2020

series ordinal

12

1 reference

17 March 2024

29

52

4273

KG Bhatia

1992

1 reference

17 March 2024

Medical Science Monitor

45

9

HY1

HH Niller

2003

1 reference

17 March 2024

Identifiers

DOI

10.1038/NRI1201

1 reference

8 August 2017

1 reference